PHARMOS made a net profit of CZK 11.2 mil in 2019, up 128% compared to the previous year. Historically, between 2006 and 2019, the company's net profit reached a high of CZK 44.3 mil in 2016 and a low of CZK -27.0 mil in 2012.
The result implies a return on equity of 1.72% and a return on invested capital of 0.527% in 2019. That is compared to an average of 3.03% and 1.10% over the last five years.
The company has been operating with average EBITDA margin of 0.569% in the last 5 years and an average net margin of 0.172%.
Since 2014, the firm's net profit increased by 89.5% or an average of 13.6% a year.
You can see all the company’s data at PHARMOS profile, or you can download a report on the company in the report section.
Helgi Library 
